Ausgabe 3/2010
Inhalt (36 Artikel)
Evaluation of the histological size of the sentinel lymph node metastases using RT–PCR assay: a rapid tool to estimate the risk of non-sentinel lymph node invasion in patients with breast cancer
I. Veys, S. Majjaj, R. Salgado, D. Noterman, J. C. Schobbens, F. Manouach, P. Bourgeois, J. M. Nogaret, D. Larsimont, V. Durbecq
Androgen receptor expression is a significant prognostic factor in estrogen receptor positive breast cancers
Isabella Castellano, Elena Allia, Valeria Accortanzo, Anna Maria Vandone, Luigi Chiusa, Riccardo Arisio, Antonio Durando, Michela Donadio, Gianni Bussolati, Alan S. Coates, Giuseppe Viale, Anna Sapino
The androgen receptor in breast cancer: learning from the past
Michaela J. Higgins, Antonio C. Wolff
Targeting Id1 and Id3 by a specific peptide aptamer induces E-box promoter activity, cell cycle arrest, and apoptosis in breast cancer cells
Demissew S. Mern, Karin Hoppe-Seyler, Felix Hoppe-Seyler, Jens Hasskarl, Barbara Burwinkel
Increased MUTYH mutation frequency among Dutch families with breast cancer and colorectal cancer
Marijke Wasielewski, Astrid A. Out, Joyce Vermeulen, Maartje Nielsen, Ans van den Ouweland, Carli M. J. Tops, Juul T. Wijnen, Hans F. A. Vasen, Marjan M. Weiss, Jan G. M. Klijn, Peter Devilee, Frederik J. Hes, Mieke Schutte
Penetrance of breast cancer, ovarian cancer and contralateral breast cancer in BRCA1 and BRCA2 families: high cancer incidence at older age
Dorina M. van der Kolk, Geertruida H. de Bock, Beike K. Leegte, Michael Schaapveld, Marian J. E. Mourits, Jakob de Vries, Annemieke H. van der Hout, Jan C. Oosterwijk
Cortactin gene amplification and expression in breast cancer: a chromogenic in situ hybridisation and immunohistochemical study
Konstantin J. Dedes, Maria-Angeles Lopez-Garcia, Felipe C. Geyer, Maryou B. K. Lambros, Kay Savage, Radost Vatcheva, Paul Wilkerson, Daniel Wetterskog, Magali Lacroix-Triki, Rachael Natrajan, Jorge S. Reis-Filho
The pan-DAC inhibitor LBH589 is a multi-functional agent in breast cancer cells: cytotoxic drug and inducer of sodium-iodide symporter (NIS)
N. Fortunati, M. G. Catalano, F. Marano, V. Mugoni, M. Pugliese, O. Bosco, F. Mainini, G. Boccuzzi
Expression of HAb18G is associated with tumor progression and prognosis of breast carcinoma
Fangfang Liu, Lifang Cui, Yang Zhang, Ling Chen, Yahong Wang, Yu Fan, Ting Lei, Feng Gu, Ronggang Lang, Gordon A. Pringle, Xinmin Zhang, Zhinan Chen, Li Fu
Pathological complete response after preoperative systemic therapy and outcome: relevance of clinical and biologic baseline features
Emilia Montagna, Vincenzo Bagnardi, Nicole Rotmensz, Giuseppe Viale, Giancarlo Pruneri, Paolo Veronesi, Giuseppe Cancello, Alessandra Balduzzi, Silvia Dellapasqua, Anna Cardillo, Alberto Luini, Stefano Zurrida, Oreste Gentilini, Mauro Giuseppe Mastropasqua, Luca Bottiglieri, Monica Iorfida, Aron Goldhirsch, Marco Colleoni
Primary systemic therapy for operable breast cancer patients: the need for the new generation of trial design
Ricardo H. Alvarez, Gabriel N. Hortobagyi
A practical approach to manage additional lesions at preoperative breast MRI in patients eligible for breast conserving therapy: results
Lotte E. Elshof, Emiel J. Th. Rutgers, Eline E. Deurloo, Claudette E. Loo, Jelle Wesseling, Kenneth E. Pengel, Kenneth G.A. Gilhuijs
Additional findings at preoperative MRI: a simple golden rule for a complex problem?
Francesco Sardanelli
Preoperative concurrent paclitaxel-radiation in locally advanced breast cancer: pathologic response correlates with five-year overall survival
Sylvia Adams, A. Bapsi Chakravarthy, Martin Donach, Darcy Spicer, Stella Lymberis, Baljit Singh, Joshua A. Bauer, Tsivia Hochman, Judith D. Goldberg, Franco Muggia, Robert J. Schneider, Jennifer A. Pietenpol, Silvia C. Formenti
Biomarker alterations with metronomic use of low-dose zoledronic acid for breast cancer patients with bone metastases and potential clinical significance
Xinmin Zhao, Xiaofeng Xu, Lin Guo, Joseph Ragaz, Haiyi Guo, Jiong Wu, Zhimin Shao, Ji Zhu, Xiaomao Guo, Jiayi Chen, Beiling Zhu, Zhonghua Wang, Xichun Hu
Prevalence of renal insufficiency in breast cancer patients and related pharmacological issues
Vincent Launay-Vacher, Joseph Gligorov, Christophe Le Tourneau, Nicolas Janus, Jean-Philippe Spano, Isabelle Ray-Coquard, Stéphane Oudard, Xavier Pourrat, Jean-François Morere, Gilbert Deray, Philippe Beuzeboc
BRCA1/2 test results impact risk management attitudes, intentions, and uptake
Suzanne C. O’Neill, Heiddis B. Valdimarsdottir, Tiffani A. DeMarco, Beth N. Peshkin, Kristi D. Graves, Karen Brown, Karen E. Hurley, Claudine Isaacs, Sharon Hecker, Marc D. Schwartz
RAD51 135G>C polymorphism contributes to breast cancer susceptibility: a meta-analysis involving 26,444 subjects
Zhanwei Wang, Hairong Dong, Yuanyuan Fu, Haixia Ding
HER2 Ile655Val polymorphism contributes to breast cancer risk: evidence from 27 case–control studies
Su Lu, Zhanwei Wang, Hong Liu, Xishan Hao
MTRR A66G polymorphism and breast cancer risk: a meta-analysis
Jia Hu, Guo-Wu Zhou, Ning Wang, Ya-Jie Wang
Recording of hormone therapy and breast density in breast screening programs: summary and recommendations of the International Cancer Screening Network
Brian Cox, Rachel Ballard-Barbash, Mireille Broeders, Emily Dowling, Nea Malila, Rene Shumak, Stephen Taplin, Diana Buist, Diana Miglioretti
Breast cancer in elderly compared to younger patients in the Netherlands: stage at diagnosis, treatment and survival in 127,805 unselected patients
E. Bastiaannet, G. J. Liefers, A. J. M. de Craen, P. J. K. Kuppen, W. van de Water, J. E. A. Portielje, L. G. M. van der Geest, M. L. G. Janssen-Heijnen, O. M. Dekkers, C. J. H. van de Velde, R. G. J. Westendorp
Endothelial nitric oxide synthase (eNOS) 894 G>T polymorphism is associated with breast cancer risk: a meta-analysis
Youjin Hao, Rafael Montiel, Yongsheng Huang
Association between androgen receptor gene CAG repeat polymorphism and breast cancer risk: a meta-analysis
YouJin Hao, Rafael Montiel, BingHui Li, Enyi Huang, Lewie Zeng, YongSheng Huang
Three polymorphisms in interleukin-1β gene and risk for breast cancer: a meta-analysis
Xiaoan Liu, Zhanwei Wang, Jinhua Yu, Gang Lei, Shui Wang
Plasma tea polyphenol levels and subsequent risk of breast cancer among Japanese women: a nested case–control study
Motoki Iwasaki, Manami Inoue, Shizuka Sasazuki, Tsutomu Miura, Norie Sawada, Taiki Yamaji, Taichi Shimazu, Walter C. Willett, Shoichiro Tsugane
A longitudinal study of factors associated with perceived risk of recurrence in women with ductal carcinoma in situ and early-stage invasive breast cancer
Ying Liu, Maria Pérez, Mario Schootman, Rebecca L. Aft, William E. Gillanders, Matthew J. Ellis, Donna B. Jeffe
Breast-conserving therapy after previous irradiation for lymphoma
Sonia K. A. Nguyen, Anne Dagnault
No evidence for DNA methylation of von Hippel-Lindau ubiquitin ligase complex genes in breast cancer
Katie T. Huang, Alexander Dobrovic, Stephen B. Fox
Screening RAD51C nucleotide alterations in patients with a family history of breast and ovarian cancer
Yonglan Zheng, Jing Zhang, Kisha Hope, Qun Niu, Dezheng Huo, Olufunmilayo I. Olopade
Diagnosis of second breast cancer events after initial diagnosis of early stage breast cancer
Diana S. M. Buist, Linn A. Abraham, William E. Barlow, Arun Krishnaraj, Regan C. Holdridge, Edward A. Sickles, Patricia A. Carney, Karla Kerlikowske, Berta M. Geller
Maternal and paternal lineage double heterozygosity alteration in familial breast cancer: a first case report
Brunella Pilato, Simona De Summa, Katia Danza, Rossana Lambo, Angelo Paradiso, Stefania Tommasi
Clinical significance of a serum CA 15-3 surge and the usefulness of CA 15-3 kinetics in monitoring chemotherapy response in patients with metastatic breast cancer
Shih-Chung Wu, Fong-Fu Chou, Kun-Ming Rau
Glutathione S-transferase P1 Ile105Val polymorphism and breast cancer risk: convergence and divergence of the two recent meta-analyses
Konstantinos P. Economopoulos, Theodoros N. Sergentanis